Report #2873895

Received Nov 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 53 yrs
State: WA
Recovered: Unknown
Vaccinated: Nov 5, 2025
Onset: Nov 5, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	NR4T5	—

Symptoms (1)

Product preparation issue

Symptom narrative

Only the adjuvant portion of Shingrix administered.; Inappropriate dose of vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number NR4T5, expiry date 26-APR-2027) for prophylaxis. On 05-NOV-2025, the patient received Shingrix. On 05-NOV-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Only the adjuvant portion of Shingrix administered.) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date:14-NOV-2025 The Nurse reported that, the patient was administered only the adjuvant portion (diluent only) of Shingrix. Registered nurse wanted to know next steps to take and if the patient needed to be revaccinated. The reporter consented to follow up.